Causaly raises $60M for its drug discovery and biomedical research platform powered by AI - Next Digital Health

We know that the entire world is experiencing a phenomenon called AI, which is now everywhere we go and has been seen in medical research as well. Now, there is an AI-based medical research platform named Causaly, founded by Yiannis Kiachopoulos, one of its co-founders. Their company, which is just over six years old, already
read more..